Literature DB >> 11527761

Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE.

P Brown-Peterside1, E Rivera, D Lucy, I Slaughter, L Ren, M A Chiasson, B A Koblin.   

Abstract

Project ACHIEVE, which conducts HIV prevention research studies, maintains a women's site in the South Bronx in NewYork City. Owing to a focused retention effort at the South Bronx site, high retention rates were achieved in a vaccine preparedness study for women at high risk of HIV infection. Comparable retention rates have been achieved in HIV vaccine trials with similar cohorts of women at this site. These results suggest that concerns about retaining hard-to-reach populations should not cause these populations to be excluded from HIV vaccine and prevention trials.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527761      PMCID: PMC1446784          DOI: 10.2105/ajph.91.9.1377

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  A perspective on AIDS vaccines.

Authors:  B R Bloom
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

Review 2.  Reframing women's risk: social inequalities and HIV infection.

Authors:  S Zierler; N Krieger
Journal:  Annu Rev Public Health       Date:  1997       Impact factor: 21.981

3.  Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.

Authors:  P Brown-Peterside; M A Chiasson; L Ren; B A Koblin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

4.  Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.

Authors:  B A Koblin; P Heagerty; A Sheon; S Buchbinder; C Celum; J M Douglas; M Gross; M Marmor; K Mayer; D Metzger; G Seage
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

Review 5.  Retaining and tracking cohort study members.

Authors:  J R Hunt; E White
Journal:  Epidemiol Rev       Date:  1998       Impact factor: 6.222

  5 in total
  16 in total

1.  Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?

Authors:  Paula M Frew; Matthew Archibald; Nina Martinez; Carlos del Rio; Mark J Mulligan
Journal:  Challenge (Atlanta Ga)       Date:  2007

2.  Study retention as bias reduction in a hard-to-reach population.

Authors:  Bruce Western; Anthony Braga; David Hureau; Catherine Sirois
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 3.  Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.

Authors:  Joalida Smit; Keren Middelkoop; Landon Myer; Graham Lindegger; Leslie Swartz; Soraya Seedat; Tim Tucker; Robin Wood; Linda-Gail Bekker; Dan J Stein
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

Review 4.  Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention.

Authors:  Shayesta Dhalla; Gary Poole
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Building Partnerships and Stakeholder Relationships for HIV Prevention: Longitudinal Cohort Study Focuses on Community Engagement.

Authors:  Rondalya D DeShields; Jonathan Paul Lucas; Melissa Turner; Kemi Amola; Valarie Hunter; Stephanie Lykes; Anne M Rompalo; Sten H Vermund; Suzanne Fischer; Danielle F Haley
Journal:  Prog Community Health Partnersh       Date:  2020

6.  Transition from Birth to Ten to Birth to Twenty: the South African cohort reaches 13 years of age.

Authors:  Linda M Richter; Shane A Norris; Thea De Wet
Journal:  Paediatr Perinat Epidemiol       Date:  2004-07       Impact factor: 3.980

7.  Factors influencing HIV vaccine community engagement in the urban South.

Authors:  Paula M Frew; Carlos del Rio; Sarah Clifton; Matthew Archibald; Joseph T Hormes; Mark J Mulligan
Journal:  J Community Health       Date:  2008-08

8.  Successful techniques for retaining a cohort of infants and children born to HIV-infected women: the prospective P2C2 HIV study.

Authors:  Kimberly Geromanos; Susan N Sunkle; Mary Beth Mauer; Diane Carp; Jessica Ancker; Weihong Zhang; Kirk A Easley; Mark D Schluchter; Claudia A Kozinetz; Robert B Mellins
Journal:  J Assoc Nurses AIDS Care       Date:  2004 Jul-Aug       Impact factor: 1.354

9.  Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064).

Authors:  Danielle F Haley; Jonathan Lucas; Carol E Golin; Jing Wang; James P Hughes; Lynda Emel; Wafaa El-Sadr; Paula M Frew; Jessica Justman; Adaora A Adimora; Christopher Chauncey Watson; Sharon Mannheimer; Anne Rompalo; Lydia Soto-Torres; Zandraetta Tims-Cook; Yvonne Carter; Sally L Hodder
Journal:  AIDS Patient Care STDS       Date:  2014-04       Impact factor: 5.078

10.  Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.

Authors:  Paula M Frew; Carlos del Rio; Lu Lu; Sarah Clifton; Mark J Mulligan
Journal:  J Acquir Immune Defic Syndr       Date:  2009-03-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.